BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18956950)

  • 1. Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.
    Worth Longest P; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):99-112. PubMed ID: 18956950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of generation time on spray aerosol transport and deposition in models of the mouth-throat geometry.
    Worth Longest P; Hindle M; Das Choudhuri S
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):67-83. PubMed ID: 18956949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Wei X; Hindle M; Kaviratna A; Huynh BK; Delvadia RR; Sandell D; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):358-371. PubMed ID: 29878859
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental Study of Spiriva Respimat Soft Mist Inhaler Spray Characterization: Size Distributions and Velocity.
    Alatrash A; Mehri R; Ogrodnik N; Matida E; Fiorenza F
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):293-302. PubMed ID: 31259646
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative analysis and design of a spray aerosol inhaler. Part 1: effects of dilution air inlets and flow paths.
    Longest PW; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):271-83. PubMed ID: 19466904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model.
    Hindle M; Longest PW
    Pharm Res; 2010 Sep; 27(9):1800-11. PubMed ID: 20454837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis and design of a spray aerosol inhaler. Part 2: improvements in mouthpiece performance.
    Hindle M; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):237-47. PubMed ID: 23098326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo-in vitro comparison of deposition in three mouth-throat models with Qvar and Turbuhaler inhalers.
    Zhang Y; Gilbertson K; Finlay WH
    J Aerosol Med; 2007; 20(3):227-35. PubMed ID: 17894531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler.
    Coates MS; Chan HK; Fletcher DF; Chiou H
    Pharm Res; 2007 Aug; 24(8):1450-6. PubMed ID: 17404813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.
    Longest W; Hassan A; Farkas D; Hindle M
    Pharm Res; 2022 Feb; 39(2):295-316. PubMed ID: 35147870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler.
    Dhand R; Eicher J; Hänsel M; Jost I; Meisenheimer M; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():509-523. PubMed ID: 30880941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonuniform Deposition of Pressurized Metered-Dose Aerosol in Spacer Devices.
    Ogrodnik N; Azzi V; Sprigge E; Fiset S; Matida E
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):490-500. PubMed ID: 27224033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Soft Mist Inhaler Aerosol Velocity, Size, and Deposition Inside the Mouth-A Computational Fluid Dynamics Study.
    Sadeghi T; Pakzad L; Fatehi P
    J Biomech Eng; 2023 Jun; 145(6):. PubMed ID: 36826406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the spray velocities from a pressurized metered-dose inhaler.
    Crosland BM; Johnson MR; Matida EA
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):85-97. PubMed ID: 18956946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway.
    Ahookhosh K; Saidi M; Mohammadpourfard M; Aminfar H; Hamishehkar H; Farnoud A; Schmid O
    Eur J Pharm Sci; 2021 Sep; 164():105911. PubMed ID: 34129919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.